These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21211076)

  • 21. Advancing palliative care as a human right.
    Gwyther L; Brennan F; Harding R
    J Pain Symptom Manage; 2009 Nov; 38(5):767-74. PubMed ID: 19783399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Solidarity with the healthcare sector is not boundless].
    Bos GM
    Ned Tijdschr Geneeskd; 2010; 154(51-52):A2974. PubMed ID: 21211085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer.
    Limat S; Bracco-Nolin CH; Legat-Fagnoni C; Chaigneau L; Stein U; Huchet B; Pivot X; Woronoff-Lemsi MC
    Eur J Health Econ; 2006 Jun; 7(2):107-13. PubMed ID: 16474968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost determinants in aggressive non-Hodgkin's lymphoma.
    van Agthoven M; Sonneveld P; Verdonck LF; Uyl-de Groot CA
    Haematologica; 2005 May; 90(5):661-71. PubMed ID: 15921381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haematology and palliative care: blood, sweat and tears.
    Newton S
    Intern Med J; 2003 Dec; 33(12):549-51. PubMed ID: 14656224
    [No Abstract]   [Full Text] [Related]  

  • 26. Is paclitaxel and cisplatin a cost-effective first-line therapy for advance ovarian carcinoma?
    Covens A; Boucher S; Roche K; Macdonald M; Pettitt D; Jolain B; Souetre E; Rivière M
    Cancer; 1996 May; 77(10):2086-91. PubMed ID: 8640674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of the cost of first line chemotherapy in metastatic colorectal cancer. Preliminary results in the FFCD 9601 trial].
    Locher C; Auperin A; Boige V; Alzieu L; Pignon JP; Abbas M; Ducreux M
    Gastroenterol Clin Biol; 2001; 25(8-9):749-54. PubMed ID: 11598535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palliative chemotherapy.
    Ellison NM
    Am J Hosp Palliat Care; 1998; 15(2):93-103. PubMed ID: 9543897
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapy for Hematologic Cancers in Older Patients, Quality of Life, and Health Economics: Difficult Decisions.
    Deeg HJ; Steuten LM
    JAMA Oncol; 2015 Aug; 1(5):571-2. PubMed ID: 26181003
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hematologic malignancies/pediatric malignancy].
    Usui N
    Gan To Kagaku Ryoho; 2013 May; 40(5):582. PubMed ID: 23957064
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hematologic and oncologic emergencies].
    von Bergwelt-Baildon M; Böll B; Shimabukuro-Vornhagen A; Kochanek M
    Med Klin Intensivmed Notfmed; 2013 Apr; 108(3):184-90. PubMed ID: 23455441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-opportunity analysis in clinical oncology: from the 'wild far-west' to a correct integration of the disciplines, avoiding the 'war of the worlds'.
    Tassinari D; Poggi B; Fantini M; Tamburini E; Nicoletti S; Sartori S
    Ann Oncol; 2006 May; 17(5):876-7; reply 877-8. PubMed ID: 16317013
    [No Abstract]   [Full Text] [Related]  

  • 33. Should we admit patients with haematological malignancy to intensive care?
    Jones C; Hewson R; Ramessur S
    Br J Hosp Med (Lond); 2009 Sep; 70(9):544. PubMed ID: 19749653
    [No Abstract]   [Full Text] [Related]  

  • 34. Haematology and palliative care: the needs are out there.
    Porta-Sales J; Noble S
    Palliat Med; 2019 May; 33(5):481-482. PubMed ID: 31060466
    [No Abstract]   [Full Text] [Related]  

  • 35. A palliative care model and conceptual approach suited to clinical malignant haematology.
    Button E; Bolton M; Chan RJ; Chambers S; Butler J; Yates P
    Palliat Med; 2019 May; 33(5):483-485. PubMed ID: 30688149
    [No Abstract]   [Full Text] [Related]  

  • 36. Palliative care for patients with hematological malignancies: Time for a new model.
    Zimmermann C
    Leuk Res; 2016 Sep; 48():78-9. PubMed ID: 27501270
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics and course of patients with advanced hematologic malignancies receiving specialized inpatient palliative care at a German university hospital.
    Eichenauer DA; Golla H; Thielen I; Hallek M; Voltz R; Perrar KM
    Ann Hematol; 2019 Nov; 98(11):2605-2607. PubMed ID: 31253997
    [No Abstract]   [Full Text] [Related]  

  • 38. Cupping therapy and palliative care: what about hematologic malignancies?
    Tazi I; Nafil H; Mahmal L
    J Acupunct Meridian Stud; 2013 Aug; 6(4):179. PubMed ID: 23972239
    [No Abstract]   [Full Text] [Related]  

  • 39. Define "effective" the curious case of chronic cancer.
    Berlinger N; Flamm AL
    Hastings Cent Rep; 2009; 39(6):17-20. PubMed ID: 20050366
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of Palliative Mortality Prediction Tools for People with a Hematological Malignancy: Call for Action.
    Button E; Chan R; Chambers S; Butler J; Yates P
    J Palliat Med; 2017 Aug; 20(8):802-803. PubMed ID: 28595026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.